Skip to main content
OpenTrials
Completed

NCT Number: NCT03933033

Erbium-YAG Laser Versus Platelet Rich Plasma in the Treatment of Atrophic Acne Scars

This study aim to assess the efficacy of Er-YAG laser 2940nm and PRP as a single line of treatment in comparison with combined treatment in atrophic post acne scars.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–38 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Aswan University Hospital

Aswān, 81528, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients with atrophic post acne scars classified on the basis of Goodman and Baron's Qualitative classification, no active acne lesions and patients with atrophic scars only

Exclusion criteria

  • patients with positive history of keloidal tendency, positive history of bleeding tendency, platelet disorder, patients with any acute infection on face like, herpes, folliculitis, patients with HIV, HBsAg, patients with a history of autoimmune diseases or patients on immunosuppressive drugs.

Treatment and study plan

Fractional Erbium Yağ Laser

Device

Multiple sessions of Fractional Erbium Yağ Laser

Platelet rich plasma

Procedure

Multiple injections of Platelet Rich Plasma

Primary outcomes

  1. Change in grade of acne scares according toQualitative scarring grading system of Goodman and Baron

    Time frame: 6 months

    Grade of acne scares improvement after treatment

  2. Change in clinical appearance of acne scare accordinga four-point scale for assessment of clinical improvement of skin smoothness

    Time frame: 6 month

    improvement of acne scares as evaluated by sequential photos

  3. Change in patient satisfaction usinga four-point scale; Grade 4 highly satisfied, Grade 3 satisfied, Grade 2 neutral and Grade 1 dissatisfied

    Time frame: 6 month

    increase in patient satisfaction after treatment

Sponsors and collaborators

Lead sponsor

Aswan University Hospital

Other

Collaborators

  • South Valley University

Registry information

Official study title

Fractional Erbium-YAG Laser Versus Platelet Rich Plasma in the Treatment of Atrophic Acne Scars: A Randomized Clinical Trial

Important dates

Study start
2017
Primary completion
2018
Study completion
2019
First posted
May 1, 2019
Registry last updated
May 1, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.